1. Home
  2. AVNW vs ZURA Comparison

AVNW vs ZURA Comparison

Compare AVNW & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aviat Networks Inc.

AVNW

Aviat Networks Inc.

HOLD

Current Price

$21.88

Market Cap

274.4M

Sector

Technology

ML Signal

HOLD

Logo Zura Bio Limited

ZURA

Zura Bio Limited

HOLD

Current Price

$3.68

Market Cap

252.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVNW
ZURA
Founded
2006
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
274.4M
252.9M
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
AVNW
ZURA
Price
$21.88
$3.68
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
9
Target Price
$32.50
$11.38
AVG Volume (30 Days)
112.0K
398.3K
Earning Date
11-04-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.03
N/A
Revenue
$453,497,000.00
N/A
Revenue This Year
$5.73
N/A
Revenue Next Year
$6.79
N/A
P/E Ratio
$20.97
N/A
Revenue Growth
10.72
N/A
52 Week Low
$15.80
$0.97
52 Week High
$26.83
$4.68

Technical Indicators

Market Signals
Indicator
AVNW
ZURA
Relative Strength Index (RSI) 48.99 49.91
Support Level $20.81 $3.66
Resistance Level $21.38 $3.94
Average True Range (ATR) 0.89 0.23
MACD 0.06 -0.03
Stochastic Oscillator 56.81 46.24

Price Performance

Historical Comparison
AVNW
ZURA

About AVNW Aviat Networks Inc.

Aviat Networks Inc is a networking solutions provider. It designs, manufactures and sells wireless networking products, solutions, and services to mobile and fixed operators, private network operators, government agencies, transportation and utility companies, public safety agencies, and broadcast network operators around the world. The company's product categories include point-to-point microwave and millimeter wave radios that are licensed (subject to local frequency regulatory requirements), lightly licensed and license-exempt (operating in license-exempt frequencies), and element and network management software.

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

Share on Social Networks: